Global health risk framework research and development of medical products : workshop summary / Theresa Wizemann, Michelle A. Mancher, and Anne B. Claiborne, rapporteurs ; Board on Health Sciences Policy, Institute of Medicine, The National Academies of Sciences, Engineering, Medicine.

Author/creator Global Health Risk Framework: Research and Development of Medical Products (Workshop)
Format Electronic
Publication InfoWashington, DC : The National Academies Press, [2015]
Descriptionxvi, 123 pages ; 23 cm
Supplemental ContentFull text available from Ebook Central - Academic Complete
Subjects
Diseases--Risk factors.
World health.
Epidemiology.
Mortality.

Other author/creatorWizemann, Theresa M.
Other author/creatorMancher, Michelle.
Other author/creatorClaiborne, Anne B.
Other author/creatorInstitute of Medicine (U.S.). Board on Health Sciences Policy.
Variant title Research and development of medical products
Abstract "Since the 2014 Ebola outbreak many public- and private-sector leaders have seen a need for improved management of global public health emergencies. The effects of the Ebola epidemic go well beyond the three hardest-hit countries and beyond the health sector. Education, child protection, commerce, transportation, and human rights have all suffered. The consequences and lethality of Ebola have increased interest in coordinated global response to infectious threats, many of which could disrupt global health and commerce far more than the recent outbreak. In order to explore the potential for improving international management and response to outbreaks the National Academy of Medicine agreed to manage an international, independent, evidence-based, authoritative, multistakeholder expert commission. As part of this effort, the Institute of Medicine convened four workshops in summer of 2015 to inform the commission report. The presentations and discussions from the Workshop on Research and Development of Medical Products are summarized in this report"-- Publisher's description.
General note"The Workshop on Research and Development of Medical Products is one of the four workstream activities of the Global Health Risk Framework Initiative ... The workshop was co-hosted by the Institute of Medicine (IOM) and the University of Hong Kong, in Hong Kong, on August 19-21, 2015"--Page 2-3.
Bibliography noteIncludes bibliographic references (pages 87-88).
Access restrictionAvailable only to authorized users.
Technical detailsMode of access: World Wide Web
Genre/formElectronic books.
LCCN 2016448289
ISBN9780309380997 (pbk.)
ISBN0309380995

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available